Business Blockbuster - Helpng business to be more visible on Google

Business Daily Media


.

Hong Kong Baptist University research unveils association between plasma metabolites and COVID-19 antibody levels in recovered patients

HONG KONG SAR - Media OutReach - 10 October 2022 - A study led by Hong Kong Baptist University (HKBU) has revealed the association between rapidly fading antibody levels in some recovered COVID-19 patients and a high plasma concentration of a metabolite called glycylproline (gly-pro) and its producing enzyme.



A research team led by Professor Cai Zongwei (left) and Dr Yang Zhu (right) has revealed the association between rapidly fading antibody levels in some recovered COVID-19 patients and a high plasma concentration of a metabolite called gly-pro and its producing enzyme.
A research team led by Professor Cai Zongwei (left) and Dr Yang Zhu (right) has revealed the association between rapidly fading antibody levels in some recovered COVID-19 patients and a high plasma concentration of a metabolite called gly-pro and its producing enzyme.

The researchers also found that the application of an inhibiting agent can counteract the activities of gly-pro and its producing enzyme, and this helped to maintain COVID-19 antibody levels in a mouse model. The findings offer important insights that could aid the development of novel therapeutic and vaccination strategies against the virus.

The research results have been published in the Proceedings of the National Academy of Sciences (PNAS), a renowned international scientific journal.

Antibody levels drop in some recovered COVID-19 patients

The levels of COVID-19 antibodies among individuals in a community are crucial for herd immunity against the virus. In general, recovered COVID-19 patients have high antibody levels as a result of their natural immune reactions. However, antibody levels in some recovered COVID-19 patients have been seen to drop rapidly over the course of a few weeks, and the underlying mechanism of this phenomenon remains poorly understood.

Since the beginning of the pandemic, research studies have revealed changes in plasma cytokine and metabolite levels in COVID-19 patients. Based on these observations, a research team led by Professor Cai Zongwei, Chair Professor of the Department of Chemistry and Director of the State Key Laboratory of Environmental and Biological Analysis, and Dr Yang Zhu, the first author of this paper and a Research Assistant Professor of the Department of Chemistry at HKBU, investigated how plasma cytokines and metabolites are associated with antibody levels in recovered COVID-19 patients.

Metabolite gly-pro associated with antibody levels

The research team analysed the cytokine and metabolite profiles in the plasma samples of three subject groups. The first group included 17 recovered COVID-19 patients with steady COVID-19 antibody levels; the second group included 30 recovered COVID-19 patients with rapidly fading COVID-19 antibody levels; the third one was a control group comprising 35 individuals who had not been infected with COVID-19.

A series of quantitative computational analyses that involved the use of machine learning techniques were used to compare the levels of different plasma cytokines and metabolites in the three subject groups in relation to their COVID-19 antibody levels. The researchers then compared the two recovered patient groups with the control group, and any cytokines and metabolites with significantly different levels between the two groups and the control group were shortlisted. Among the shortlisted targets, the levels of seven cytokines and 20 metabolites were seen to differ significantly between the two groups of recovered COVID-19 patients.

The researchers then analysed the association between the selected cytokines and metabolites and COVID-19 antibody levels in recovered patients. From the collected data, they concluded that the plasma concentration of the metabolite gly-pro had increased the most in the two recovered patient groups compared with the control group.

Overall, the levels of gly-pro in the recovered patient group with rapidly fading antibody levels were four times higher than the control group, while the levels of gly-pro in the recovered patient group with steady COVID-19 antibody levels were two-and-a-half times higher than the control group. Based on these results, the researchers investigated the relationship between COVID-19 antibody levels in recovered patients and gly-pro, as well as the producing enzyme of gly-pro which is named dipeptidyl peptidase-4 (DPP4).

Inhibiting gly-pro maintains steady antibody levels

The research team set up a four-week mouse model experiment to test the hypothesis that high gly-pro levels are associated with a rapid drop in COVID-19 antibody levels in recovered COVID-19 patients. Four groups of 12 mice were injected with the spike protein of the COVID-19 virus. The groups were then respectively treated with: (1) exogenous gly-pro; (2) an inhibitor that blocks the degradation of endogenous gly-pro; (3) exogenous gly-pro and a DPP4 inhibitor (Sitagliptin, which is also an anti-diabetic drug); and (4) saline.

The serum COVID-19 antibody levels in all groups were similar in the first week of the experiment. The antibody levels of the mice in the first group declined after the second week, suggesting that increased gly-pro levels are associated with a decline in COVID-19 antibody levels. The antibody levels of the mice in the second group, who had relatively steady gly-pro levels, also began to decline in the third week. The slower decline in antibody levels in the second group of mice compared to the first group shows that varying amounts of gly-pro are associated with the amount of time a steady antibody level can be maintained.

Meanwhile, the antibody levels of the mice in the third group remained stable throughout the experiment. This shows that when the activities of DPP4 are inhibited, the negative effects of gly-pro can be neutralised, and a steady level of COVID-19 antibodies can be maintained.

New insights for therapeutic and disease control strategies

Professor Cai said: "Effective shield immunity for a community against the spread of COVID-19 is highly dependent on the maintenance of steady antibody levels in individuals. Our experimental results suggest that DPP4 inhibitors can effectively maintain steady antibody levels in COVID-19-infected mice. As a result, our study offers important insights into how we can develop a similar medical approach to maintain COVID-19 antibody levels in humans, which will contribute to the global fight against the pandemic."

Dr Yang said: "Further studies based on our research findings are warranted to explore the potential in other areas of therapeutic and disease control, especially in terms of other applications. For example, novel strategies may be developed to enhance the efficiency of vaccination in boosting antibody levels in humans, particularly in diabetic patients, a well-known high-risk population for COVID-19."

Hashtag: #HongKongBaptistUniversity

News from Asia

XTransfer, VPBank and SmartPay Announce Partnership at Singapore FinTech Festival 2026

Empowering SMEs in Vietnam–China and Vietnam–ASEAN TradeSINGAPORE – Media OutReach Newswire – 19 November 2026 – XTransfer, the world's leading B2B cross-border trade payment platform, VPBank, a...

Columbia Asia Hospital Tebrau and Columbia Asia Hospital Iskandar Puteri jointly achieve Malaysia Book of Records recognition for their Mega Parenthood Workshop 2026

JOHOR BAHRU, MALAYSIA – Media OutReach Newswire – 19 November 2026 – Becoming a parent is one of life's most beautiful journeys, filled with excitement, questions and, at times, uncertainty. Recog...

Lambency Detailing becomes GTECHNIQ Accredited Detailer at both outlets and launches its new e-commerce website

Partnership brings GTECHNIQ’s accredited-only Crystal Serum Ultra to Ubi and Bukit Batok with a 10-year warranty; the new lambencydetailing.com launches the same day with online purchase and bookin...

Uthoppia House Founder Yusup Ngadimin Receives 2026 Spirit of Enterprise Start-up Award

Recognition marks a milestone in the Singapore AI company’s journey to help individuals and employers make more informed career and talent decisionsSINGAPORE– Media OutReach Newswire – 19 November...

UnionPay International Debuts Digital Trade Solution at CIIE 2026, Streamlining Cross-Border B2B Settlement for Global E-Commerce

SHANGHAI, CHINA – Media OutReach Newswire – 19 November 2026 — UnionPay International (UPI), together with Bank of China and Shanghai E&P International, today officially unveiled its Digital T...

DNA Brands Co Marks Fourth Anniversary, Building on Its Growth in Singapore’s Beauty and Wellness Industry

Celebrating four years of progress, the Singapore company looks to elevate its achievements through people, innovation and a shared passion for beauty and wellness as self-care becomes an increasin...

LittleLives, Little Lab and SEGi College Sign MOU to Explore Early Childhood Education Collaboration Across ASEAN

SUBANG JAYA, MALAYSIA - Media OutReach Newswire - 20 November 2026 – LittleLives, Little Lab and SEGi College signed a Memorandum of Understanding (MOU) on 5 November 2026 to explore collaboration...

Bosideng Marks 50 Years with ‘Warmth Code’ Exhibition in Shanghai

SHANGHAI, CHINA – Media OutReach Newswire – 20 November 2026 – Bosideng marked its 50th anniversary with 'Warmth Code: Half a Century of History', a landmark exhibition at Gate M West Bund Dream C...

Sixth Asia International Innovation and Invention Hong Kong Showcases Over 180 Innovations from the Asia-Pacific

Hong Kong Exporters’ Association’s “Hong Kong Innovation and Invention” Program exhibits at Entrepreneur Day for the fourth consecutive yearHONG KONG SAR – Media OutReach Newswire – 20 November 20...

Travel Insurance Was Built for the Few Who Claim. Ancileo’s Felt Coverage™ is for Everyone Else

There are now two kinds of travel insurance: coverage that’s contracted, and coverage that’s felt. Ancileo is the first to introduce the latter.SINGAPORE – Media OutReach Newswire – 20 November 20...

New Research Highlights What Australian Retailers Need to Deliver

New research among Australian SHEIN customers reveals how price comparisons, product quality and customer reviews are shaping purcha...

Why the secrecy around car insurance?

Every year, millions of Australians receive their car insurance renewal and promise themselves they’ll look at it properly later. Then life gets in ...

Australian workers spend almost an hour a day administering email

Research finds email filing, searching and rework consuming an estimated 58 minutes a day and potentially exposing organisations to millionsAustralian...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...